BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ngai D, Mohabeer AL, Mao A, Lino M, Bendeck MP. Stiffness-Responsive Feedback Autoregulation of DDR1 Expression is Mediated by a DDR1-YAP/TAZ Axis. Matrix Biol 2022:S0945-053X(22)00070-1. [PMID: 35562016 DOI: 10.1016/j.matbio.2022.05.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Liu J, Wang J, Liu Y, Xie SA, Zhang J, Zhao C, Zhou Y, Pang W, Yao W, Peng Q, Wang X, Zhou J. Liquid-Liquid Phase Separation of DDR1 Counteracts the Hippo Pathway to Orchestrate Arterial Stiffening. Circ Res 2023;132:87-105. [PMID: 36475898 DOI: 10.1161/CIRCRESAHA.122.322113] [Reference Citation Analysis]
2 Tian Y, Bai F, Zhang D. New target DDR1: A "double-edged sword" in solid tumors. Biochim Biophys Acta Rev Cancer 2022;1878:188829. [PMID: 36356724 DOI: 10.1016/j.bbcan.2022.188829] [Reference Citation Analysis]
3 Borza CM, Bolas G, Pozzi A. Genetic and pharmacological tools to study the role of discoidin domain receptors in kidney disease. Front Pharmacol 2022;13:1001122. [DOI: 10.3389/fphar.2022.1001122] [Reference Citation Analysis]
4 Sirvent A, Espie K, Papadopoulou E, Naim D, Roche S. New functions of DDR1 collagen receptor in tumor dormancy, immune exclusion and therapeutic resistance. Front Oncol 2022;12:956926. [DOI: 10.3389/fonc.2022.956926] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Pereira M, Matuszewska K, Glogova A, Petrik J. Mutant p53, the Mevalonate Pathway and the Tumor Microenvironment Regulate Tumor Response to Statin Therapy. Cancers 2022;14:3500. [DOI: 10.3390/cancers14143500] [Reference Citation Analysis]